Molecular Response After Concurrent Exercise With Low Glycogen

Healthy Clinical Trial

— Glyconcurrent  

Official title:

The Effects of Glycogen Availability on the Skeletal Muscle Molecular Response After Concurrent Exercise

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02668445
• Other study ID #: NL54408.081.15
• Status: Completed
• Phase: N/A
• Start date: November 2015
• Est. completion date: April 2016

Study information

• Verified date: February 2016
• Source: Wageningen University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This is a randomized, counterbalanced crossover design, in which 14 male subjects will complete two experimental trials. Each trial will be separated by a minimum of at least 12 days (range: 12-30 days). The study aims to investigate the effects of low glycogen availability on skeletal muscle molecular response after a concurrent exercise day.

Description:

Two experimental exercise trials; a low carbohydrate (= LOW) and a high carbohydrate (= HIGH) trial. During both experimental days subjects will complete an continues submaximal cycling bout in the morning followed by a resistance exercise session in the early afternoon. During the LOW trial subjects will receive a low carbohydrate mixed meal, during the HIGH trial subjects will be provided with a high carbohydrate meal. In addition, on both experimental days subjects will receive adequate protein beverages. Lastly, protein will be provided post resistance exercise.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 14
• Est. completion date: April 2016
• Est. primary completion date: February 2016
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Male
• Age group: 18 Years to 30 Years

Eligibility

Inclusion Criteria:

• Male gender between 18 and 30 years of age

• BMI between 18.5 - 25 kg/m2

• Participating in regular exercise training (at least 1 exercise session, and a maximum of 3 exercise session per week)

• Used to different types of exercise (endurance, resistance and/or concurrent)

• Willing to give blood samples

• Willing to give muscle biopsies

• No use of antibiotics during the study or in the past month

• No drug use

• Suitable veins for blood withdrawal

• Registered by a general-practitioner

• Consumption of alcohol beverages is less than 21 per week

• No blood donor during the study

• No vegetarian and willing to eat meat during the experimental days

• Able to be present and participate at both test days and pre testing moments

• Not employed, or intern, or working on thesis at the department of Human Nutrition at Wageningen University

• Not participating in another scientific study (except EetMeetWeet)

• Able to participate during the experimental days en pre tests

• Able to speak Dutch

Exclusion Criteria:

• Medical condition that can interfere with the study outcome (i.e. cardiovascular disease, pulmonary disease, gluten intolerance)

• Systolic blood pressure >160 mmHg and/or diastolic blood pressure >100 mmHg

• Use of medications known to interfere with gene expression in the muscles (i.e. statins, fenofibrate)

• Use of antithrombotic therapy (marcoumar, sintromitis).

• Diagnosed diabetes mellitus type 1 or 2

• (Chronic) injuries of the locomotor system that can interfere with the intervention

Related Conditions & MeSH terms

• Healthy

Intervention

Other:
• Standard meal containing low or high carbohydrate content

Locations

Country	Name	City	State
Netherlands	Division of Human Nutrition, Wageningen University	Wageningen	Gelderland

Sponsors (1)

Lead Sponsor	Collaborator
Wageningen University

Country where clinical trial is conducted

Netherlands, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Proteins involved in hypertrophy		10 hours